pET28a-C9ORF80
(Plasmid
#128418)
-
PurposeExpress C9ORF80 in E. coli with a His tag (C-terminal)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 128418 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET28a
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5369
- Total vector size (bp) 5545
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameC9ORF80
-
Alt nameHSSBIP1
-
Alt nameSOSS-C
-
Alt nameINIP (INTS3 And NABP Interacting Protein)
-
SpeciesH. sapiens (human)
-
GenBank IDNM_021218.3
-
Entrez GeneINIP (a.k.a. C9orf80, HSPC043, MISE, SOSSC, SSBIP1, hSSBIP1)
- Promoter T7
-
Tag
/ Fusion Protein
- His (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Nco I (not destroyed)
- 3′ cloning site Xho I (not destroyed)
- 5′ sequencing primer T7 promoter
- 3′ sequencing primer T7 terminator (Common Sequencing Primers)
Resource Information
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET28a-C9ORF80 was a gift from Yuliang Wu (Addgene plasmid # 128418 ; http://n2t.net/addgene:128418 ; RRID:Addgene_128418) -
For your References section:
Biochemical characterization of INTS3 and C9ORF80, two subunits of hNABP1/2 heterotrimeric complex in nucleic acid binding. Vidhyasagar V, He Y, Guo M, Talwar T, Singh RS, Yadav M, Katselis G, Vizeacoumar FJ, Lukong KE, Wu Y. Biochem J. 2018 Jan 2;475(1):45-60. doi: 10.1042/BCJ20170351. 10.1042/BCJ20170351 PubMed 29150435